The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis

BACKGROUND: Schizophrenia is a chronic and debilitating neuropsychiatric disorder that often requires long-term pharmacotherapy to manage symptoms and prevent relapse. Cariprazine is a potent dopamine D(3) and D(2) receptor partial agonist that is FDA-approved in the US for the treatment of schizoph...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Psychiatry
Main Authors: Nasrallah, Henry A., Earley, Willie, Cutler, Andrew J., Wang, Yao, Lu, Kaifeng, Laszlovszky, István, Németh, György, Durgam, Suresh
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5571492/
https://ncbi.nlm.nih.gov/pubmed/28836957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-017-1459-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados